Framework for prioritizing variants of unknown significance from clinical genetic testing in kidney disease: utility of multidisciplinary approach to gather evidence of pathogenicity for Hepatocyte Nuclear Factor-1 (HNF1B) p.Arg303His
暂无分享,去创建一个
P. Igarashi | D. Carey | J. Hoenderop | U. Mirshahi | J. D. de Baaij | S. Ferrè | L. Tholen | K. Patel | A. Cook | A. Bhan | B. Fang | A. R. Chang | P. Mohan | B. Moore | G. Chen | J. D. de Baaij